Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies

Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies

Pemphigus is a rare autoimmune blistering disease, involving potentially life-threatening conditions often requiring immunosuppression. Currently, the COVID-19 pandemic caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2) infection has become a global public emergency. Vaccines are...

Full description

Bibliographic Details
Main Authors: Xueyi Huang, Xiaoqian Liang, Jiao Zhang, Hang Su, Yongfeng Chen
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
autoimmune bullous diseases
pemphigus
COVID-19
vaccination
Rituximab
management strategies
Online Access:https://www.mdpi.com/2077-0383/11/14/3968

Internet

https://www.mdpi.com/2077-0383/11/14/3968

Similar Items